Yu Shunjie, Ren Xiaotong, Meng Fanqiao, Guo Xinyu, Tao Jinglian, Zhang Wei, Liu Zhaoyun, Fu Rong, Li Lijuan
Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China. Address:Heping District 154 Anshan Road, Tianjin, China.
Immunology. 2023 Feb;168(2):273-289. doi: 10.1111/imm.13488. Epub 2022 May 3.
Myeloid-derived suppressor cells (MDSC) induced cellular immune deficiency and bone marrow inflammatory microenvironment play an important role in the pathogenesis and progression of myelodysplastic syndrome (MDS), but the underlying mechanism remains unclear. Here, we revealed that immune checkpoint protein TIM3 and CEACAM1 were highly demonstrated on MDSC and CD8 T cells in MDS patients. CD8 T cells were reduced in number and function and presented a exhaustion state. The levels of pro-inflammatory cytokines (IL-1β, IL-18) and CEACAM1 were raised in bone marrow supernatants and MDSC culture supernatants. Blocking or neutralizing TIM3/CEACAM1 and IL-1β/IL-18 partially reversed exhaustion of CD8 T cells. Moreover, TIM3 correlated with NF-κB /NLRP3 inflammatory pathway. The levels of NF-κB/NLRP3/Caspase-1/IL-1β and IL-18 were all increased in MDSC of MDS. Co-culturing MDSC from MDS patients with rhCEACAM1 enhanced NF-κB/NLRP3/Caspase-1/IL-1β and IL-18 levels, whereas blocking TIM3 could partially reverse the above manifestations. These results indicated that TIM3/CEACAM1 pathway involved in CD8 T cells exhaustion and might activate the NF-κB/NLRP3/Caspase-1 pathway in MDSC, increasing pro-inflammatory cytokines secretion in MDS bone marrow microenvironment. This study provided a basis for applying immune checkpoint inhibitors that could simultaneously modulate pro-inflammatory cytokine secretion and enhance anti-tumour immune function in the treatment of MDS.
髓系来源的抑制性细胞(MDSC)诱导的细胞免疫缺陷和骨髓炎性微环境在骨髓增生异常综合征(MDS)的发病机制和进展中起重要作用,但其潜在机制仍不清楚。在此,我们发现免疫检查点蛋白TIM3和CEACAM1在MDS患者的MDSC和CD8 T细胞上高度表达。CD8 T细胞数量减少且功能受损,并呈现耗竭状态。骨髓上清液和MDSC培养上清液中促炎细胞因子(IL-1β、IL-18)和CEACAM1水平升高。阻断或中和TIM3/CEACAM1以及IL-1β/IL-18可部分逆转CD8 T细胞的耗竭。此外,TIM3与NF-κB/NLRP3炎性途径相关。MDS患者的MDSC中NF-κB/NLRP3/Caspase-1/IL-1β和IL-18水平均升高。将MDS患者的MDSC与重组CEACAM1共培养可提高NF-κB/NLRP3/Caspase-1/IL-1β和IL-18水平,而阻断TIM3可部分逆转上述表现。这些结果表明,TIM3/CEACAM1途径参与CD8 T细胞耗竭,并可能激活MDSC中的NF-κB/NLRP3/Caspase-1途径,增加MDS骨髓微环境中促炎细胞因子的分泌。本研究为应用可同时调节促炎细胞因子分泌并增强抗肿瘤免疫功能的免疫检查点抑制剂治疗MDS提供了依据。